340 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
21 Recruiting Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions: Adult Solid Neoplasm;   Advanced Malignant Neoplasm;   Cervical Squamous Cell Carcinoma;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Ovarian Carcinoma;   Recurrent Renal Cell Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Sarcoma;   Stage III Bladder Cancer;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IIIC1 Uterine Corpus Cancer;   Stage IIIC2 Uterine Corpus Cancer;   Stage IV Breast Cancer;   Stage IV Ovarian Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Bladder Cancer;   Stage IVA Cervical Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Bladder Cancer;   Stage IVB Cervical Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nanoparticle Albumin-Bound Rapamycin;   Other: Quality-of-Life Assessment
22 Not yet recruiting Study of Enadenotucirev and Pembrolizumab in Subjects With Metastatic or Advanced Epithelial Tumors
Conditions: Colorectal Cancer;   Bladder Carcinoma;   Squamous Cell Carcinoma of the Head and Neck;   Salivary Gland Cancer
Interventions: Biological: enadenotucirev;   Biological: pembrolizumab
23 Not yet recruiting Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
Conditions: Biliary Carcinoma;   Gall Bladder Carcinoma;   Cholangiocarcinoma;   Gastrointestinal Tumor
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Copanlisib
24 Not yet recruiting Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Condition: Bladder Cancer
Intervention: Biological: pembrolizumab
25 Not yet recruiting Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder
Condition: Muscle-invasive Urothelial Cancer of the Bladder
Interventions: Biological: Pembrolizumab;   Procedure: Transurethral Resection of Bladder Tumor;   Drug: Gemcitabine;   Radiation: External Beam Radiation Therapy
26 Not yet recruiting Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System
Condition: Overactive Bladder
Intervention: Device: Axonics Sacral Neuromodulation (SNM) System
27 Recruiting Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)
Condition: Refractory Overactive Bladder
Intervention: Device: PINS SNS
28 Not yet recruiting Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Urinary Bladder Neoplasms
Interventions: Drug: Pembrolizumab;   Drug: Vorinostat
29 Not yet recruiting Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Condition: Urinary Bladder, Neurogenic
Interventions: Other: Clean Intermittent Catheterization;   Other: Indwelling Catheter;   Other: Bladder Surgery
30 Recruiting Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.
Condition: Overactive Bladder
Intervention: Drug: Fesoterodine
31 Not yet recruiting LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Conditions: Urinary Bladder Neoplasms;   Ureteral Neoplasms;   Urethral Neoplasms
Intervention: Drug: Crizotinib
32 Recruiting Enzalutamide for Bladder Cancer Chemoprevention
Condition: Bladder Cancer
Intervention: Drug: Enzalutamide
33 Recruiting A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients
Conditions: Urinary Incontinence;   Overactive Bladder
Intervention: Biological: Botulinum Toxin Type A
34 Not yet recruiting Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery
Conditions: Prostatic Neoplasms;   Urinary Bladder Neoplasms
Interventions: Procedure: low-pressure pneumoperitoneum;   Procedure: standard-pressure pneumoperitoneum
35 Not yet recruiting Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)
Conditions: UTI;   Neurogenic Bladder
Interventions: Drug: Uro vaxom;   Other: Placebo comparator
36 Recruiting Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Conditions: Interstitial Cystitis;   Bladder Pain Syndrome
Interventions: Drug: URG101;   Drug: Placebo;   Drug: Lidocaine;   Drug: Heparin
37 Recruiting A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India
Conditions: Urinary Incontinence;   Overactive Bladder
Intervention: Biological: botulinum toxin Type A
38 Recruiting Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation
Conditions: Overactive Bladder;   Parkinson Disease
Interventions: Device: Back Tibial Nerve Electrostimulation;   Device: Placebo Electrostimulation
39 Not yet recruiting Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder
Condition: Urinary Bladder, Neurogenic
Intervention: Device: EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine
40 Not yet recruiting The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury
Conditions: Spinal Cord Injury;   Neurogenic Bladder
Interventions: Device: Transcutaneous Tibial Nerve Stimulation;   Device: Control

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years